citalopram has been researched along with Raynaud Disease in 2 studies
Citalopram: A furancarbonitrile that is one of the serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia.
citalopram : A racemate comprising equimolar amounts of (R)-citalopram and its enantiomer, escitalopram. It is used as an antidepressant, although only escitalopram is active.
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile : A nitrile that is 1,3-dihydro-2-benzofuran-5-carbonitrile in which one of the hydrogens at position 1 is replaced by a p-fluorophenyl group, while the other is replaced by a 3-(dimethylamino)propyl group.
Raynaud Disease: An idiopathic vascular disorder characterized by bilateral Raynaud phenomenon, the abrupt onset of digital paleness or CYANOSIS in response to cold exposure or stress.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buecking, A | 1 |
| Rougemont, E | 1 |
| Fabio Zullino, D | 1 |
| Peiró, AM | 1 |
| Margarit, C | 1 |
| Torra, M | 1 |
2 other studies available for citalopram and Raynaud Disease
| Article | Year |
|---|---|
Treatment of Raynaud's phenomenon with escitalopram.
Topics: Adult; Antidepressive Agents, Second-Generation; Citalopram; Female; Humans; Raynaud Disease | 2005 |
Citalopram-induced Raynaud's phenomenon.
Topics: Adult; Analgesics; Citalopram; Depressive Disorder; Female; Humans; Neuralgia; Raynaud Disease; Sele | 2007 |